Edition:
United Kingdom

Cellular Biomedicine Group Inc (CBMG.OQ)

CBMG.OQ on NASDAQ Stock Exchange Global Market

20.50USD
20 Apr 2018
Change (% chg)

$-0.20 (-0.97%)
Prev Close
$20.70
Open
$20.80
Day's High
$21.30
Day's Low
$20.50
Volume
8,888
Avg. Vol
13,490
52-wk High
$22.75
52-wk Low
$5.15

Select another date:

Fri, Mar 16 2018

BRIEF-Cellular Biomedicine Announces Positive Clinical Data Of Knee Osteoarthritis China Phase I Trial

* CELLULAR BIOMEDICINE GROUP ANNOUNCES POSITIVE 48-WEEK CLINICAL DATA OF ALLOJOIN™ HUMAN ADIPOSE-DERIVED MESENCHYMAL PROGENITOR CELL (HAMPC) KNEE OSTEOARTHRITIS (KOA) CHINA PHASE I TRIAL

BRIEF-Cellular Biomedicine Group Reports Full-Year 2017 Financial Results And Recent Operational Progress

* CELLULAR BIOMEDICINE GROUP REPORTS FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS

BRIEF-Cellular Biomedicine Files For Resale Of Up To 2.9 Mln Shares By Selling Stockholders ‍​

* CELLULAR BIOMEDICINE GROUP FILES FOR RESALE OF UP TO 2.9 MILLION SHARES BY SELLING STOCKHOLDERS - SEC FILING ‍​ Source: (http://bit.ly/2oKEYbP) Further company coverage:

BRIEF-Cellular Biomedicine Group Announces $30.6 Mln Investment From Sailing Capital Overseas Investment

* CELLULAR BIOMEDICINE GROUP ANNOUNCES $30.6 MILLION INVESTMENT FROM SAILING CAPITAL OVERSEAS INVESTMENT LTD.

BRIEF-Cellular Biomedicine Group Says Enters Securities Purchase Agreement With Certain Investors

* CELLULAR BIOMEDICINE GROUP SAYS ON JAN 30, CO ENTERED INTO A SECURITIES PURCHASE AGREEMENT WITH CERTAIN INVESTORS - SEC FILING

BRIEF-Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility

* CELLULAR BIOMEDICINE GROUP INC - ANNOUNCED PLAN TO CONFIGURE PART OF ITS FACILITY IN SHANGHAI WITH GE HEALTHCARE'S FLEXFACTORY PLATFORM

BRIEF-Cellular Biomedicine Group reports qtrly ‍loss per share $0.43

* Cellular Biomedicine Group reports third quarter financial results and recent operational highlights

BRIEF-Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes

* Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes

Select another date: